Lars Wallentin (Former)

1 – 8 of 8

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/14f8e4fa-2b92-4f97-b3da-ba06b520c317?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2021
Mark The SWEDEHEART secondary prevention and cardiac rehabilitation registry (SWEDEHEART CR registry)
Bäck, Maria ; Leosdottir, Margret ^LU ; Hagström, Emil ; Norhammar, Anna ; Hag, Emma ; Jernberg, Tomas ; Wallentin, Lars ^LU ; Lindahl, Bertil and Hambraeus, Kristina (2021) In European Heart Journal - Quality of Care and Clinical Outcomes 7(5). p.431-437
- Contribution to journal › Article
Mark Mendelian randomisation identifies alternative splicing of the FAS death receptor as a mediator of severe COVID-19
Klaric, Lucija ; Gisby, Jack S ; Papadaki, Artemis ; Muckian, Marisa D ; Macdonald-Dunlop, Erin ; Zhao, Jing Hua ; Tokolyi, Alex ; Persyn, Elodie ; Pairo-Castineira, Erola and Morris, Andrew P , et al. (2021)
- Working paper/Preprint › Preprint in preprint archive
2019
Mark A catalog of genetic loci associated with kidney function from analyses of a million individuals
Wuttke, Matthias ; Almgren, Peter ^LU ; Lindgren, Cecilia M ^LU ; Melander, Olle ^LU ; Orho-Melander, Marju ^LU ; Perola, Markus ^LU ; Schulz, Christina-Alexandra ^LU ; Thomsen, Hauke ^LU ; Wallentin, Lars ^LU and Pattaro, Cristian (2019) In Nature Genetics 51(6). p.957-972
- Contribution to journal › Article
2017
Mark Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk
Brænne, Ingrid ; Zeng, Lingyao ; Willenborg, Christina ; Tragante, Vinicius ; Kessler, Thorsten ; Willer, Cristen J ; Laakso, Markku ; Wallentin, Lars ^LU ; Franks, Paul W ^LU and Salomaa, Veikko , et al. (2017) In PLoS ONE 12(8). p.0182999-0182999
- Contribution to journal › Article
2016
Mark Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction - A registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)
Erlinge, David ^LU ; Koul, Sasha ^LU ; Eriksson, Peter ; Scherstén, Fredrik ^LU ; Omerovic, Elmir ; Linder, Rikard ; Östlund, Olof Petter ; Wallentin, Lars ^LU ; Fröbert, Ole and James, Stefan (2016) In American Heart Journal 175. p.36-46
- Contribution to journal › Article
Mark Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction : Experiences from SWEDEHEART registry
Sahlén, Anders ; Varenhorst, Christoph ; Lagerqvist, Bo ; Renlund, Henrik ; Omerovic, Elmir ; Erlinge, David ^LU ; Wallentin, Lars ^LU ; James, Stefan K. and Jernberg, Tomas (2016) In European Heart Journal 37. p.3335-3342
- Contribution to journal › Article
2015
Mark Ticagrelor versus clopidogrel in patients with acute coronary syndromes and chronic obstructive pulmonary disease : An analysis from the platelet inhibition and patient outcomes (plato) trial
Andell, Pontus ^LU ; James, Stefan K. ; Cannon, Christopher P. ; Cyr, Derek D. ; Himmelmann, Anders ; Husted, Steen ; Keltai, Matyas ; Koul, Sasha ^LU ; Santoso, Anwar and Steg, Ph Gabriel , et al. (2015) In Journal of the American Heart Association 4(10). p.1-25
- Contribution to journal › Article
2010
Mark 1/4 av all vård är onödig eller skadlig
Rehnquist, Nina ; Lohmander, Stefan ^LU ; Nordin, Pär ; Wallentin, Lars ^LU and Herlitz, Johan (2010) In Läkartidningen 107(1-2).
- Contribution to journal › Debate/Note/Editorial